EvidenceSync exists because evidence teams carry enormous strategic responsibility with tooling that was never designed for it. We're changing that with a governed, AI-native platform built specifically for pharmaceutical evidence work. Built by people who've spent careers inside pharmaceutical development and enterprise data infrastructure. Our team brings decades of experience in evidence generation and enterprise architecture, we've run the workflows EvidenceSync governs.
EvidenceSync is a registered trade name of Intelligent Biopharma.
Our mission is to give evidence leaders one governed record of their evidence strategy, with the intelligence to find what is missing, the discipline to score what matters, and the traceability to defend every decision. We want the next generation of evidence teams to plan with confidence and answer hard questions with the rationale already on the record.
It should be planned, connected, scored, and defended like any other strategic asset.
Medical Affairs, HEOR, Regulatory, Publications, and Market Access each hold a piece of the record. Value leaks in the space between them.
If you cannot compare two evidence activities on the same scale, you cannot prioritize them honestly.
In regulated environments, a recommendation you cannot trace to source is a liability, not an insight.
EvidenceSync is built for Medical Affairs, Evidence Generation, HEOR, Regulatory Intelligence, Publications, and Market Access teams who are accountable for evidence strategy and the spend behind it, and for the executives and governance leaders who have to defend that strategy.
Digital transformation is rapidly accelerating across pharmaceutical evidence planning. Be at the forefront of this evolution.